# Phase II Study of Liposomal Doxorubicin in Platinum- and Paclitaxel-Refractory Epithelial Ovarian Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-ii-study-of-liposomal-doxorubicin-in-platinum-and-paclitaxel-refractory/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alan N. Gordon,C.O. Granai,Peter G. Rose,John D. Hainsworth,A. B. Lopez,Charles Weissman,Rosemary Rosales,Tim Sharpington |
| Citations | 344 |
| DOI | 10.1200/jco.2000.18.17.3093 |
| Fields | Materials Science,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2202035925 |
| PMID | 10963637 |
| Type | article |
| Year | 2000 |

## Paper authors

- [Peter G. Rose](https://scholariq.org/researchers/peter-g-rose/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Nanoparticle-Based Drug Delivery](https://scholariq.org/topics/nanoparticle-based-drug-delivery/)

## Paper topics

- [Nanoparticle-Based Drug Delivery](https://scholariq.org/topics/nanoparticle-based-drug-delivery/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.